113 related articles for article (PubMed ID: 38678851)
1. Lipoic acid alters the microRNA signature in breast cancer cells.
Khalife H; Fayyad-Kazan M; Fayyad-Kazan H; Hadchity E; Borghol N; Hussein N; Badran B
Pathol Res Pract; 2024 May; 257():155321. PubMed ID: 38678851
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression Profiles of the Transcriptome in Breast Cancer Cell Lines Revealed by Next Generation Sequencing.
Shi Y; Ye P; Long X
Cell Physiol Biochem; 2017; 44(2):804-816. PubMed ID: 29176322
[TBL] [Abstract][Full Text] [Related]
5. The role of vulpinic acid as a natural compound in the regulation of breast cancer-associated miRNAs.
Cansaran-Duman D; Yangın S; Çolak B
Biol Res; 2021 Nov; 54(1):37. PubMed ID: 34743742
[TBL] [Abstract][Full Text] [Related]
6. The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells.
Dozio E; Ruscica M; Passafaro L; Dogliotti G; Steffani L; Marthyn P; Pagani A; Demartini G; Esposti D; Fraschini F; Magni P
Eur J Pharmacol; 2010 Sep; 641(1):29-34. PubMed ID: 20580704
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide miRNA response to anacardic acid in breast cancer cells.
Schultz DJ; Muluhngwi P; Alizadeh-Rad N; Green MA; Rouchka EC; Waigel SJ; Klinge CM
PLoS One; 2017; 12(9):e0184471. PubMed ID: 28886127
[TBL] [Abstract][Full Text] [Related]
8. alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells.
Lee HS; Na MH; Kim WK
Nutr Res; 2010 Jun; 30(6):403-9. PubMed ID: 20650348
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
[TBL] [Abstract][Full Text] [Related]
10. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
11. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation.
Surapaneni SK; Bhat ZR; Tikoo K
Sci Rep; 2020 Oct; 10(1):17954. PubMed ID: 33087811
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
[TBL] [Abstract][Full Text] [Related]
15. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
Masuda M; Miki Y; Hata S; Takagi K; Sakurai M; Ono K; Suzuki K; Yang Y; Abe E; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S2. PubMed ID: 23227519
[TBL] [Abstract][Full Text] [Related]
16. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells.
Klinge CM; Piell KM; Tooley CS; Rouchka EC
Sci Rep; 2019 Jul; 9(1):9430. PubMed ID: 31263129
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells.
Zhong S; Ma T; Zhang X; Lv M; Chen L; Tang J; Zhao J
Gene; 2015 Feb; 556(2):113-8. PubMed ID: 25445394
[TBL] [Abstract][Full Text] [Related]
18. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
[TBL] [Abstract][Full Text] [Related]
20. Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene.
Yahya SMM; Nabih HK; Elsayed GH; Mohamed SIA; Elfiky AM; Salem SM
Breast Cancer Res Treat; 2024 Feb; 204(1):133-149. PubMed ID: 38057687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
